HARVARD APPARATUS REGENERATIVE TECHNOLOGY, inc. 1,800,000 SHARES OF COMMON STOCK AND 695,857 SHARES OF SERIES b CONVERTIBLE PREFERRED STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2015 • Harvard Apparatus Regenerative Technology, Inc. • Surgical & medical instruments & apparatus • New York
Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule VI hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 1,800,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, up to 270,000 additional shares (the “Additional Shares”) of common stock, par value $0.01 per share (the “Common Stock”) of the Company, in an offering under its registration statement on Form S-3 (File No. 333-200926) (the Firm Shares and the Additional Shares the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Offered Shares”) and an aggregate of 695,857 shares of Series B Convertible Preferred Stock, par value $0.01 per share, (the “Preferred Stock”) of the Company. The 3,479,285 shares of the Compa
AMENDMENT NO. 1 TO SHAREHOLDER RIGHTS AGREEMENTShareholder Rights Agreement • February 12th, 2015 • Harvard Apparatus Regenerative Technology, Inc. • Surgical & medical instruments & apparatus • Delaware
This Amendment No. 1 to Shareholder Rights Agreement (this “Amendment”) is entered into as of February 12, 2015, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and Computershare Trust Company, N.A., a federally chartered trust company (as successor rights agent to Registrar and Transfer Company, a New Jersey corporation) (the “Rights Agent”).
